Comparison between two types of peripheral vein catheter
Not Applicable
Active, not recruiting
- Conditions
- Pathological conditions, signs and symptoms. AdultCatheterization PeripheralComparative effectiveness research/complicationsphlebitisinfiltrationtractionextravasation of diagnostic and therapeutic materialscatheter obstructioninfection.
- Registration Number
- RBR-48z55v
- Lead Sponsor
- niversidade Federal do Paraná
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Age over 18 years; being hospitalized in research units; requires obtaining peripheral intravenous access for intravenous therapy.
Exclusion Criteria
Present peripheral venous fragility or any other condition that could impair the puncture with peripheral intravenous catheter; insertion of the catheter in the external jugular vein; have previously participated in the search, regardless of randomization group.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie phlebitis and catheter-related infection in peripheral venous catheterization studies?
How does the effectiveness of RBR-48z55v catheter types compare to standard-of-care in reducing infiltration and extravasation complications?
Which biomarkers correlate with catheter obstruction or infection risk in adult peripheral venous catheter trials?
What adverse event profiles are associated with peripheral catheter materials in clinical trials addressing traction and phlebitis?
How do alternative catheter materials or designs in RBR-48z55v compare to competitor approaches for managing diagnostic/therapeutic material extravasation?